Compounds > sn 23862
Page last updated: 2024-09-03

sn 23862 and Neoplasms

sn 23862 has been researched along with Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferry, DM; Helsby, NA; Patterson, AV; Pullen, SM; Wilson, WR1
Pruijn, FB; Wilson, WR1
Denny, WA; Helsby, NA; Hicks, KO; Hogg, A; Pullen, SM; Wilson, WR1

Other Studies

3 other study(ies) available for sn 23862 and Neoplasms

ArticleYear
2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.
    British journal of cancer, 2004, Mar-08, Volume: 90, Issue:5

    Topics: Aniline Mustard; Antineoplastic Agents; Aziridines; Bystander Effect; Chromatography, High Pressure Liquid; Escherichia coli; Genetic Therapy; Genetic Vectors; Humans; Mass Spectrometry; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured

2004
Hypoxia-activated prodrugs as antitumour agents: strategies for maximizing tumour cell killing.
    Clinical and experimental pharmacology & physiology, 1995, Volume: 22, Issue:11

    Topics: Aniline Mustard; Animals; Antineoplastic Agents; Cell Hypoxia; Mice; Neoplasms; Nitrogen Mustard Compounds; Prodrugs; Xanthenes; Xanthones

1995
Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
    Cancer research, 2002, Mar-01, Volume: 62, Issue:5

    Topics: Aniline Mustard; Animals; Aziridines; Bystander Effect; Cell Culture Techniques; Cricetinae; Genetic Therapy; Humans; Neoplasms; Nitroreductases; Prodrugs; Structure-Activity Relationship; Tumor Cells, Cultured

2002